Cascade Pharmaceuticals
Nanjing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An oncology-focused biotech developing targeted small molecule therapies using structure-based drug design.
Oncology
Technology Platform
Structure-based drug design platform leveraging X-ray crystallography and computational modeling to develop selective small molecule kinase inhibitors and other targeted therapies.
Opportunities
Strong investor interest in precision oncology and potential for licensing deals with global pharmaceutical companies seeking novel targeted agents.
Risk Factors
Clinical failure risk in competitive tumor types and dependence on successful trial readouts for further funding.
Competitive Landscape
Operates in the densely populated field of kinase inhibitors, requiring clear differentiation in efficacy or safety to stand out.